Hallmark star secretly battles throat cancer

Hallmark star John Reardon reveals he had tonsil cancer: ‘Has been a long road.'
John Reardon has revealed that he was diagnosed with tonsil cancer. The Canadian actor, 49, has starred in Citytv's “Hudson & Rex" since 2019, and is also known for his roles in Hallmark Christmas films such as “Believe in Christmas,” which premiered last month.
Hallmark star secretly battles throat cancer, says he's been on a 'long road' to recovery
Actor John Reardon, known for his role in the Hallmark movie "Believe in Christmas," shared a health update on social media as he posted a photo of himself hospitalized after he revealed he had throat cancer.
Hallmark star John Reardon shares recovery from tonsil cancer
The Hallmark actor known for roles in "Believe in Christmas" and the TV series "Hudson & Rex" thanked his family and medical staff for their support amid his recovery.
Hallmark Star John Reardon Shares Tonsil Cancer Diagnosis In Emotional Social Media Post: It’s “Been A Long Road”
Believe in Christmas star John Reardon announced he is currently recovering from tonsil cancer in an emotional social media post thanking his loved ones for their support. The Hallmark star shared a photo from the hospital on Instagram,
Hallmark Stars John Reardon and Meghan Ory's Relationship Timeline
John Reardon and Meghan Ory didn't meet on a Hallmark Channel movie - but their love story plays out like one. The twosome were introduced while filming their short-lived series Merlin's Apprentice in 2006.
Health on MSN6d
Study Finds Many Americans Don't Know That HPV Can Cause This Type of Cancer
Public awareness of the dangers of HPV and the benefits of the vaccine are low, according to two recent students. Experts ...
verywellhealth on MSN11d
The HPV Vaccine Protects Against More Than Just Cervical Cancer, Experts Say
Most Americans are unaware of the link between HPV and throat cancer, despite the virus causing 70% of cases. With low ...
Pharmaceutical Technology4d
Zanzalintinib fumarate by Exelixis for Oropharyngeal Cancer: Likelihood of Approval
Zanzalintinib fumarate is under clinical development by Exelixis and currently in Phase III for Oropharyngeal Cancer.
McKnight's Long-Term Care News2d
Risk for head and neck cancer lower for coffee and tea drinkers
Coffee and tea drinkers have a reduced risk for head and neck cancer (HNC), according to research published online Dec. 23 in ...
Cervical cancer deaths drop among younger women; study credits HPV vaccine
The HPV vaccine has led to a significant drop in cervical cancer deaths among younger women, with a 62 percent decline in ...
Business Insider20d
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC, a clinical-stage biotech company ...
Hosted on MSN6d
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
In the latest statistical salvo of an ongoing debate, people who consumed more than four cups of caffeinated coffee daily had ...